Guardant Health prices $500 million convertible senior notes offering
- Guardant Health priced $500 million of 0% convertible senior notes maturing May 15, 2032.
- Initial purchasers received an option to buy an additional $50 million of notes, potentially increasing the offering to $550 million.
- Settlement is scheduled for November 16, 2026.
- The initial conversion price is approximately $208.95 per share, a 35% premium to the November 11 closing price.
- Assuming full option exercise, approximately $501.7 million of net proceeds will fund repurchases of outstanding 0% convertible senior notes due 2027.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611120109BIZWIRE_USPR_____20261111_BW786767) on November 12, 2026, and is solely responsible for the information contained therein.